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Abstract
Background: Daylily flowers, the flower and bud parts of Hemerocallis citrina or H. fulva, are well known as Wang-You-
Cao in Chinese, meaning forget-one’s sadness plant. However, the major types of active constituents responsible for
the neurological effects remain unclear. This study was to examine the protective effects of hydroalcoholic extract and
fractions and to identify the active fractions.
Methods: The extract of daylily flowers was separated with AB-8 resin into different fractions containing non-phenolic
compounds, phenolic acid derivatives and flavonoids as determined using UPLC-DAD chromatograms. The
neuroprotective activity was measured by evaluating the cell viability and lactate dehydrogenase release using
PC12 cell damage models induced by corticosterone and glutamate. The neurological mechanisms were explored by
determining their effect on the levels of dopamine (DA), 5-hydroxy tryptamine (5-HT), γ-aminobutyric acid
(GABA), noradrenaline (NE) and acetylcholine (ACh) in the cell culture medium measured using an LC-MS/
MS method.
Results: Pretreatment of PC12 cells with the extract and phenolic fractions of daylily flowers at concentrations ranging
from 0.63 to 5 mg raw material/mL significantly reversed corticosterone- and glutamate-induced neurotoxicity in a
dose-dependent manner. The fractions containing phenolic acid derivatives (0.59% w/w in the flowers) and/or
flavonoids (0.60% w/w) exerted similar dose-dependent neuroprotective effect whereas the fractions with non-
phenolic compounds exhibited no activity. The presence of phenolic acid derivatives in the corticosterone- and
glutamate-treated PC12 cells elevated the DA level in the cell culture medium whereas flavonoids resulted in
increased ACH and 5-HT levels.
Conclusion: Phenolic acid derivatives and flavonoids were likely the active constituents of daylily flowers and
they conferred a similar extent of neuroprotection, but affected the release of neurotransmitters in a different
manner.
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Highlights
The hydroalcoholic extract was separated into phenolic
and non-phenolic factions.
Phenolic fractions contained phenolic acid derivatives
and flavonoids.
Phenolics but not non-phenolics showed neuroprotection
to PC12 damaged cells.
Phenolic acid derivatives affected the release of dopamine
and noradrenaline.
Flavonoids affected the release of serotonin noradrenaline
and acetylcholine.
Background
Daylily flowers, commonly called yellow flower vegetable
(Huang-Hua-Cai), golden needle vegetable (Jin-Zhen-
Cai) and Xuan-Cao flower in China, are the flower and
bud parts of Hemerocallis citrina Baroni or H. fulva (L.)
L.. Traditionally, apart from being food materials, the
herb has been used as an anodyne, febrifuge, sleep-
promoting and sedative agent, and for stimulating the
secretion of milk for women in childbirth in China [1].
It is also well known as Wang-You-Cao in Chinese,
meaning forget-one’s sadness plant, and has been
recorded to exhibit antidepressant effects in ancient
medical books of China, including the famous textbook
“Compendium of Materia Medica”.
In modern pharmacological and clinical studies, the
neurological actions of daylily flowers have been docu-
mented. Several studies showed that significant sleep-
promoting and sedative effects were elicited in mice
treated with daylily flowers or the extracts compared
with mice in control group [2–4]. In a clinical study,
daylily flowers exhibited significant better efficacy in
treating insomnia than the control treatment with
diazepam [2]. In addition, many previous studies have
also demonstrated that the hydroalcoholic extracts of
daylily flowers conferred antidepressant-like effects in
acute stress-induced, chronic unpredictable mild stress-
induced and corticosterone-induced depression-like models
of rodents and improving learning and memory in animal
models [5–10]. In these studies, the underlying mecha-
nisms for the central nervous system (CNS) modulating
effects were not entirely clear and were considered to at
least partly involve in the anti-inflammatory property and
the ability to mediate the brain levels of monoamine neuro-
transmitters such as serotonin (5-HT), noradrenaline (NE)
and dopamine (DA) [7, 9, 10].
The major constituents responsible for the CNS
modulating effects remain unclear. Some previous
studies speculated that such effects might be related
to flavonoids [8, 9]. Indeed, Du and colleagues found
that in comparison to the aqueous extract, the higher
flavonoid content in the alcohol extracts of daylily
flowers resulted in better biological activities [9]. In
particular, the work also revealed that the combination
of rutin and hesperidin, two main flavonoid ingredients,
displayed similar antidepressant-like effect to the alcohol
extracts. In our previous in vivo screening study on the
active ingredients of daylily flowers, the fraction containing
~60% flavonoids exhibited significant antidepressant-like
effects whereas the fraction lack of flavonoids showed no
effect in mice model by forced swimming test, tail suspen-
sion test and antagonism reserpine experiments [11]. How-
ever, daylily flowers contain various types of chemical
ingredients including flavonoids, phenolic acids and deriva-
tives, di- and tri-terpenes, essential oils, steroidal saponins,
alkaloids, amino acids, polysaccharides and so on [12], the
potential neurological effects of other constituents in daylily
flowers are largely uninvestigated. Therefore, the objectives
of this study were to separate the extracts of daylily flowers
into different fractions and to evaluate the neuroprotective
effects of each fraction using PC12 cell damage models
induced by corticosterone and glutamate with also a view
to identifying the active fractions and their potential effect
on the neurotransmitter release in the cell culture medium.
Methods
Plant materials and reagents
Hemerocallis citrina was obtained from Qidong county,
Hunan province, China. The rat pheochromocytoma cells
(PC12) were purchased from the Cell Culture Center of
Chinese Academy of Medical Sciences (Beijing, China).
Dulbecco’s modified eagle medium (DMEM), penicillin,
streptomycin, nonessential amino acids, and fetal bovine
serum were purchased from Gibco (New York, USA).
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide), corticosterone and hydrogen peroxide, DA, 5-
HT, γ-aminobutyric acid (GABA), NE, acetylcholine (ACh)
and 3, 4-dihydroxy benzylamine (DHBA) were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Glutamate was
purchased from Amresco (Solon, USA). Lactate dehydro-
genase (LDH) diagnostic kit was purchased from Nanjing
Jiancheng Bioengineering Institute (Nanjing, China). Aceto-
nitrile and MeOH of HPLC grade were obtained from
Merck (Darmstadt, Germany), and formic acid of HPLC
grade was from Dima (Lake Forest, CA, USA). Water was
purified by a Milli-Q water purification system (Millipore,
MA, USA). All other chemicals and reagents were of
analytical grade.
Ultra Performance Liquid Chromatography (UPLC)
chromatographic and UPLC/MS conditions
The UPLC system consisted of a Waters Acquity Ultra
Performance LC System, a Waters photodiode array de-
tector, Empower software (Waters, Milford, MA, USA),
and a Kinetex C18 column (100 mm × 2.1 mm, 1.7 μm,
Phenomenx, USA). The column temperature was set at
30 °C. A gradient mobile phase system consisting of
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acetonitrile:H2O (3:97 to 20:80 from 0 to 20 min, 20:80
to 80:20 from 20 to 22 min, 80:20 to 3:97 from 22 to
23 min, 3:97 from 23 to 27 min) with 0.1% formic acid
as a modifier was used to elute the analytes after 2 μL of
sample solution was applied onto the column whereas
the detection wavelength was set at 340 nm [12]. The
flow rate was 0.2 mL/min and the sample temperature
was maintained at 4 °C.
For the identification of chemical constituents, UPLC/
MS analysis was performed using a Waters ACQUITY
UPLC system (Waters Corporation, Milford, MA, USA)
coupled with a Waters Micromass Q-TOF micro™
Synapt High-Definition Mass Spectrometer (Manchester,
UK) equipped with electrospray ionization source (ESI)
operating in positive ion mode. The main parameters
such as capillary voltages, sample cone voltage and ex-
traction cone voltage were set at 3.0 kV, 40 V and 4.0 V,
respectively. Nitrogen was used as the drying gas. The
desolvation gas rate was set to 800 L/h at 450 °C, the
cone gas rate at 40 L/h, and the source temperature at
120 °C. The scan time and inter scan delay were set 0.15
and 0.02 s, respectively.
Extraction and separation
The plants came from Qidong (Hunan, China) and were
authenticated by Professor Ben-Gang Zhang, the Institute
of Medicinal Plant Development (IMPLAD), Chinese
Academy of Medical Sciences and Peking Union Medical
College, Beijing, China. And the voucher specimen (No.
20150507) was deposited in the herbarium of IMPLAD.
Briefly, the raw material of H. citrina flowers (250 g) was
extracted once with 2.5 L of 90% EtOH under reflux using
a water bath for 2 h and then extracted twice with 1.5 L of
70% EtOH under reflux using a water bath for 1 h. The
extract solutions were combined, filtered and subse-
quently concentrated by using a rotary evaporator under
reduced pressure at 60 °C to completely remove the
ethanol. The concentrated crude extract was diluted to
500 mL and applied to AB-8 macroporous adsorption
resin column chromatography (1000 g), followed by
eluting with 4 L water, 5 L 10% EtOH, 5 L 30% EtOH,
5 L 50% EtOH and 5 L 95% EtOH, the corresponding
elutes were concentrated under reduced pressure at
60 °C and lyophilized into powders [13]. The 10%, 30%
and 50% EtOH fractions were further subjected to
separation in Sephadex LH20 and each fraction was
divided into two fractions, namely phenolic and non-
phenolic parts, respectively.
Cell culture and treatment
PC12 cells were cultured in DMEM supplemented with
10% heat-inactivated fetal bovine serum, 5% heat-
inactivated horse serum, 100 U/mL penicillin and 100 μg/
mL streptomycin in a humidified 95 air and 5% CO2
atmosphere at 37 °C. For all experiments, cells in the loga-
rithmic phase were harvested. To study the protective
effect of H. citrina extract and fractions, the PC12
cell damage models were induced by corticosterone
(250 μmol/L) and glutamic acid (20 mmol/L). PC12
cells were divided into non-treated control, damage
model and damage models administrated with test
extracts or fractions in all experiments. The PC12
cells were cultured in a 96-well plate at a density of
1 × 104 cells/well. Then cells were treated with cor-
ticosterone or glutamate and incubated for 24 h ac-
cording to previous studies [14, 15], DMEM with
different concentrations (equivalent to 0.3125, 0.625,
1.25, 2.5 and 5.0 mg raw material/mL) of extracts or
fractions were added and incubated for 24 h.
MTT and LDH activity assays
The Cell viability was determined using an MTT assay.
After incubation, the PC12 cells were treated with MTT
solution (working concentration at 0.5 mg/mL) for 4 h
at 37 °C. Subsequently, the formazan crystals formed in
the intact cells were solubilized with 150 μl of DMSO,
and absorbance at 470/590 nm was measured with a mi-
croplate reader (Spectrafluor, TECAN, Sunrise, Austria).
Cell viability was expressed as a percentage of the
control.
The cell damage was evaluated by determining the re-
leased LDH using a LDH diagnostic kit according to the
manufacturer’s protocol. At the end of incubation, the
medium was collected, 100 μL of the medium was added
to a polystyrene cuvette containing 1 mL of LDH
reagent. The cuvette was immediately placed into a
spectrophotometer and maintained at 37 °C. After
1 min-stabilization, the absorbance at 340 nm was
recorded at 1 min intervals for 3 min. The change in
absorbance was expressed in concentration units per
liter. All experiments were carried out in triplicate.
Measurement of neurotransmitter levels in PC12 cell
culture medium
The determination of neurotransmitter levels was used a
previously reported LC-MS/MS method [16]. The PC12
cells were cultured in 24-well plate with a density of 5 ×
104 cells/well following the protocol described in the
Section 2.4. After treatment and incubation, the culture
medium was harvested whereas the cells were detached
from the wells by trypsin treatment and pelleted cells
were then lysed by sonication in 0.1 M perchlorate and
centrifugated at 12,000 rpm for 3 min, and supernatants
were used for the determination of total protein content.
The total protein contents of cell supernatants were
measured using BCA protein assay following the manu-
facture’s protocol. Prior to LC-MS/MS analysis, 20 μL of
30 μg/mL DHBA (internal standard) was added to the
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culture medium, which was subjected to protein precipi-
tation by adding MeOH at a volume ratio of MeOH:H2O
2:1. The samples were then vortexed and centrifuged,
and the supernatant were subjected to freeze-drying.
The freeze-dried samples were reconstituted in 200 μL
MeOH:H2O (1:1) and centrifugated at 12,000 rpm for
3 min. The neurotransmitter levels in the medium were
normalized by the corresponding total protein content.
Two independent experiments were performed with a
representative experiment shown.
Statistical analysis
The statistical analyses were performed with SPSS statis-
tics 17.0. All values were expressed as mean ± SD, unless
stated. Data were analyzed using the two tailed, unpaired
Student’s t-test or factorial analysis of variance (ANOVA),
followed by post hoc comparisons using the Dunnett’s or
Student-Newman-Keuls (SNK) tests if the ANOVA mani-
fested a significant difference. A two-tailed P value of 0.05
or less was taken to indicate statistical significance.
Results
Extraction and separation
The UPLC chromatographic fingerprint of phenolic
compounds was used for the quality control of H. citrina
samples in this study. Among the peaks in the UPLC
chromatograms from nine batches of herbal samples
(Fig. 1a), 9 major compounds were selected for the
discrimination study. The crude EtOH extracts of H.
citrina was further separated using AB-8 macroporous
adsorption resin column chromatography and eluted
with water, 10%, 30%, 50% and 95% EtOH sequentially
to give water, 10%, 30%, 50% and 95% EtOH fractions,
respectively. Each fraction was analyzed by UPLC-UV
method and the typical chromatograms are shown in
Fig. 1b, which shows that the phenolic compounds were
present in the 10%, 30% and 50% EtOH fractions and
the water and 95% EtOH fractions contained negligible
amount of phenolics.
The phenolic constituents of daylily flowers have been
previously studied with phenolic acid derivatives and fla-
vonoid glycosides representing the major types of phenolic
compounds and naphthalene and xanthone glycosides as
the minor parts [1]. In this study, the major constituents
were identified using TOF- accurate mass measurement
and UV spectra in the UPLC-DAD chromatograms. Based
on the high resolution MS, which exhibited dominant ions
at m/z 361.0891 [M + Na]+ and 147.0435 [M + H − qui-
nic acid]+ and MS2 of m/z 361 yielded an abundant ion
at m/z 147.0435 and a small ion at m/z 119.0475 [M +
H - quinic acid − CO]+, three para-coumaroylquinic
acids were identified as 3-para-coumaroylquinic acid
(Peak 2), 4-para-coumaroylquinic acid (Peak 3), and 5-
para-coumaroylquinic acid (Peak 4), respectively [17].
The peak 1 was identified as chlorogenic acid owing to
the MS, which gave two abundant ions at m/z 377.0830
[M + Na]+ and 163.0391 [M + H − quinic acid]+ [17],
whereas Peak 9 was predicted to be rutin based on the
MS spectra that exhibited abundant ions at m/z
633.1436 [M + Na]+, 465.1063 [M + H − rhamnose]+and
303.0502 [M + H − rhamnose − glucose]+ [18]. Peaks 5–
8 were unknown, however, Peak 6 was predicted to be a
phenolic acid derivatives and peak 5, 7 and 8 were un-
known flavonoids based on the UV spectra. The chro-
matographic data suggested that the 10% EtOH fraction
mainly consisted of phenolic acid derivatives whereas
the 50% EtOH fraction contained mostly flavonoids.
Considering that the 10%, 30% and 50% EtOH frac-
tions contained both phenolic and non-phenolic com-
pounds, a further separation was carried out using a
Sephadex LH-20 column, where phenolic compounds
displayed longer retention time than the non-phenolic
constituents. The separation of phenolics from the non-
phenolic compounds was confirmed in UPLC chromato-
grams (Data not shown).
Effect on corticosterone-induced cytotoxicity of PC12 cells
The viability of PC12 cells exposed to corticosterone for
24 h significantly decreased relative to the control group
(P < 0.01) with the survival rates varying from 46 to 51%
of the control when measured by an MTT assay (Figs. 2
and 3). When cells were pretreated with the extract of
H. citrina, the viability of corticosterone treated PC12
cells appeared to increase in a dose-dependent manner.
In this study, the test concentrations of extract or frac-
tions were set between 0.31 and 5.0 mg raw herb/mL.
The survival rates significantly increased compared to
the corticosterone group (P < 0.05 or 0.01) when the
dose of the extract was equivalent to 0.625 mg/mL of
raw herb or higher (Fig. 2). In addition, the eluted frac-
tions from AB-8 column were found to exhibit different
effect on the corticosterone-induced cytotoxicity of PC12
cells. The 10%, 30% and 50% EtOH fractions, which
contained phenolic compounds, appeared to exert a dose-
dependent protecting effect on the cytotoxicity of PC12
cells similar to the total extract whereas no protective
ability was shown in the water or 95% EtOH fractions
(Fig. 2).
Subsequently, the protective effects of phenolic and
non-phenolic constituents from the 10%, 30% and 50%
EtOH fractions on the viability of corticosterone treated
PC12 cells were evaluated using both MTT assay and
LDH leakage (Fig. 3). The results of the MTT assay
demonstrated that phenolic constituents from all the
three fractions exhibited protective effect in a dose-
dependent manner whereas no significant protection
was observed in the groups treated with non-phenolic
constituents. The data of LDH release, which measures
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Fig. 1 (See legend on next page.)
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cell lysis for evaluating cell damage, also showed a simi-
lar finding that phenolic constituents were responsible
for the neuroprotective effects conferred by the 10%,
30% and 50% EtOH fractions (Fig. 3).
Effects on glutamate-induced cytotoxicity of PC12 cells
Treating PC12 cells with glutamate caused a signifi-
cant decrease in the cell viability and the survival rates
were found between 43 and 51% of the control when
measured with MTT assay (Figs. 4 and 5). The results
of the MTT assay showed that the total extract, 10%,
30% and 50% EtOH fractions were dose-dependently
effective in increasing the viability of glutamate-
treated PC12 cells whereas water and 95% EtOH frac-
tions displayed no activity (Fig. 4). In addition, the
data from both MTT assay and LDH release experi-
ments in Table 1 supported that the protective effects
conferred by 10%, 30% and 50% EtOH fractions were
attributable to their phenolic constituents rather than
the non-phenolic constituents.
Effects on neurotransmitter release in the culture medium
of corticosterone-treated PC12 cells
In the medium of corticosterone-treated PC12 cells,
the contents of neurotransmitters including DA, NE,
Ach, GABA and 5-HT were analyzed in the presence
or absence of 10%, 30% and 50% EtOH fractions. As
shown in Table 1, the presence of 10 and 30% EtOH
fractions significantly increased the levels of DA and







Fig. 2 Effects of Hemerocallis citrina extract and fractions (a-f) on corticosterone (Cort) -induced cytotoxicity of PC12 cells determined by MTT
assay (mean ± SD, n = 5). ##P < 0.01 as compared with control group; *P < 0.05 and **P < 0.01 as compared with the corticosterone group
(See figure on previous page.)
Fig. 1 Chromatographic fingerprints of nine batches of Hemerocallis citrina samples (a) and the typical UPLC chromatograms of Hemerocallis
citrina fractions eluted with water (with the yield (w/w) of total extract at 21.7%, and yield of water fraction at 16.9%), 10% (the yields of EtOH
fraction, Phenolic part and non-phenolic part were 1.20%, 0.59% and 0.61%, respectively), 30% (the yields of EtOH fraction, Phenolic part and
non-phenolic part were 0.62%, 0.44% and 0.18%, respectively), 50% (the yields of EtOH fraction, Phenolic part and non-phenolic part were 0.80%,
0.60% containing 0.30% of rutin and 0.20%, respectively) and 95% EtOH (with the yield ratio at 1.54%) sequentially on an AB-8 macroporous resin
column (b)
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medium of PC12 cells, respectively whereas the treat-
ment with 50% EtOH fraction significantly affected
the levels of NE, Ach, GABA and 5-HT, but not DA.
Effects on neurotransmitter release in the culture medium
of glutamate -treated PC12 cells
The effects of phenolic constituents of daylily flowers on
neurotransmitter release in the culture medium of
glutamate-treated PC12 cells are shown in Table 1,
which suggested that the treatment with the 10%, 30%
or 50% EtOH fractions significantly enhanced the release
of NE and GABA compared with the model group (P <
0.05 or 0.01). In addition, the results indicated that the
DA release in the medium significantly increased by the
presence of 10% EtOH fraction (P < 0.05 or 0.01) but not
the 30% and 50% EtOH fractions (P > 0.05) whereas the
treatment with either 30% or 50% EtOH fractions but
not 10% EtOH fraction significantly augmented the re-
lease of Ach and 5-HT.
Discussion
Daylily flowers have been ethnopharmacologically used
to treat various CNS disorders, such as depression and
insomnia and the neuropharmacological actions have
also been demonstrated in animal models [1, 4, 7, 9].
However, the major constituents responsible for the
CNS modulating effects are yet clear, albeit that the flavo-
noids are assumed to play a role in the antidepressant-like
effects. In this study, the different types of chemical con-
stituents in the hydroalcoholic extract of daylily flowers
were fractionated using AB-8 macroporous adsorption
resin column. Upon analyzing with UPLC chromato-
grams, the phenolic constituents appeared to be mainly
present in 10%, 30% and 50% EtOH fractions whereas the
water and 95% EtOH fractions consisted of non-phenolic
constituents. Further analysis revealed that the 10% EtOH
fraction comprised mainly phenolic acids and their esters
of quinic acid whereas the 50% EtOH fraction contained
mostly flavonoids. The separation of phenolic acid deriva-







Fig. 3 Effects of phenolic and non-phenolic parts (a-f) of Hemerocallis citrina fractions on the cell viability and LDH leakage of corticosterone (Cort) -treated
PC12 cells (Mean ± SD, n =6). ##P< 0.01 as compared with control group; *P< 0.05 and**P< 0.01 as compared with the corticosterone group
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EtOH fraction was confirmed in the UPLC chromatogram
(Fig. 1b). The different retention times in the UPLC chro-
matograms between phenolic acid derivatives and flavo-
noids from daylily flowers were in well agreement with
previous findings [12].
Upon separation of different fractions, the neurological
actions of the obtained fractions and parts were assessed
using PC12 cell damage models induced by cortico-
sterone and glutamate, two in vitro models extensively
adopted for assessing neuroprotection relevant to in vivo
antidepressant activity [14, 19]. Rat pheochromocytoma
(PC12) is a cell line which has an embryonic origin from
the neural crest, and it has been employed as a useful
model to elucidate the mechanisms of cerebral disease
because of its extreme versatility for pharmacological
manipulation, ease of culture, and the large amount of
information on their proliferation and differentiation,
including releasing neurotransmitters, e.g., dopamine,
norepinephrine etc. [20]. Corticosterone, glutamate and
oxidative stresses play a critical role in the pathogenic
cascade in neurological disorders, and corticosterone,
glutamate and H2O2 induced PC12 cell injury have been
widely used as in vitro models for neuroprotection
study. For example, it has been shown that cortico-
sterone or glutamate can induce cellular damage in
PC12 cells and antidepressants could confer protection
to PC12 cells by mitigating the corticosterone/glutam-
ate-induced neurotoxicity [19, 21]. The present results
demonstrated that the hydroalcoholic extract of daylily
flowers possessed the protective activity against cortico-
sterone- and glutamate-induced damage in PC12 cells
and the protective effects were highly related to the
presence of phenolic constituents. Indeed, the lack of
phenolic constituents in the water and 95% EtOH frac-
tions did not result in any neuroprotective activity at all
whereas the presence of phenolic compounds in 10%,
30% and 50% EtOH fraction led to significant neuropro-
tection in a dose-dependent manner. In addition, both
MTT and LDH release data supported that the phenolic,
rather than the non-phenolic compounds in 10%, 30%
and 50% EtOH fractions exerted the protective effects.
Therefore, it could be deduced that the phenolic
constituents were responsible for the neuroprotective
effect of H. citrina extract. When compared the pro-
tective ability between the 10% (phenolic acid deriva-







Fig. 4 Effects of Hemerocallis citrina extract and fractions (a-f) on glutamate (Glu) -induced cytotoxicity of PC12 cells determined by MTT
assay (mean ± SD, n = 5). ##P < 0.01 as compared with control group; *P < 0.05 and **P < 0.01 as compared with the corticosterone group
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and LDH release data showed that there was no sig-
nificant difference, indicating that both phenolic acid
derivatives and flavonoids were active in attenuating
the PC12 cell damage induced by either corticosterone
or glutamate. The phenolic acid constituents present
in daylily flowers are not yet fully characterized but
include at least coumaroylquinic acids and caffeoylquinic
acid [12]. Caffeoylquinic acids have been previously demon-
strated to possess neuroprotective ability [22, 23].
Glutamate exerts both excitotoxic and toxic effects on
PC12 cells. The excitotoxicity is due to the over activa-
tion of NMDA receptors whereas glutamate-induced
cytotoxicity is mediated through the inhibition of cystine
uptake leading to depletion of GSH and oxidative toxicity
[24]. The mechanisms underlying corticosterone-induced
cytotoxicity in PC12 cells were yet elucidated, possibly in-
volving the dysfunctions of different pathways such as gly-
cerophospholipid metabolism, sphingolipid metabolism,
oxidation of fatty acids, glycerolipid metabolism and sterol
lipid metabolism [25]. Several studies suggested that the
neuroprotective effect against corticosterone-induced
cytotoxicity in PC12 cells was related to the inhibition of
oxidative stress [26]. Botanical phenolics are known to act
as antioxidants and therefore it is conceivable that the
phenolic fractions of H. citrina extract conferred pro-
tective effects against corticosterone- and glutamate-
induced cytotoxicity in PC12 cells likely via inhibition
of oxidative stress.
Deregulation of neurotransmitters such as DA, NE, ACh,
GABA and 5-HT is a key feature of CNS disorders and in-
creases in serotonergic, noradrenergic, dopaminergic and/
or cholinergic neurotransmission are considered to be rele-
vant to the most current treatments [27–30]. In this study,
the effects of the phenolic fractions of H. citrina extract on
the release of DA, NE, ACh, GABA and 5-HT in the cell
culture medium of corticosterone- and glutamate-treated
PC12 cells were investigated. PC12 cells have previ-
ously been used as a model for neurotransmitter re-
lease [20]. For example, Kozminski et al. found that
upon exposure to L-DOPA, the amount of released
catecholamines increased from PC12 cells [31]. The
present results showed that there existed differences
in the modulation of neurotransmitter release between
phenolic acid derivatives (10% EtOH fraction) and
flavonoids (50% EtOH fraction). Phenolic acid derivatives







Fig. 5 Effects of phenolic and non-phenolic parts (a-f) of Hemerocallis citrina fractions on the cell viability and LDH leakage of glutamate (Glu) -treated
PC12 cells (Mean ± SD, n = 6). ##P < 0.01 as compared with control group; *P < 0.05 and **P < 0.01 as compared with the corticosterone group
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neurotransmitter system whereas flavonoids enhanced the
release of serotonergic, noradrenergic and cholinergic
neurotransmitters. In previous animal experiments, daylily
flower extracts were reported to elevate the levels of cor-
responding neurotransmitters in the brain tissues, confer-
ring the antidepressant effects via mediating serotonergic,
noradrenergic and dopaminergic systems [7, 9, 10] and
flavonoids were assumed to be responsible. Indeed, rutin
and hesperidin, the major flavonoid ingredients of daylily
flowers [9], were proven to exert antidepressant-like
property via the central serotonergic and noradrenergic
systems [32, 33]. However, in this study, the dopamine
release was only affected by the presence of phenolic
acid derivatives rather than flavonoids. Therefore, the
phenolic acid derivatives may represent the active
constituents responsible for the mediation of dopaminergic
system, whereas flavonoids were likely responsible for the
modulation of serotonergic and noradrenergic systems.
Conclusions
The present study investigated effects of hydroalcoholic
extract of daylily on cytoprotection and neurotransmitter
release in PC12 cells. Our results demonstrated that the
hydroalcoholic extract of daylily possessed neuroprotec-
tive effects against corticosterone and glutamate-induced
damage in PC12 cells and the phenolic constituents
Table. 1 Effects of Hemerocallis citrina fractions (HF) on the extracellular levels (ng/mg proteins) of dopamine (DA), 5-hydroxy tryptamine
(5-HT), γ-aminobutyric acid (GABA), noradrenaline (NE) and acetylcholine (ACh) in corticosterone (Cort) or glutamate (Glu)-treated PC12
cells (mean ± SD, n = 5)
Analyte EtOH % extract Control Cort + Vehicle Cort + HF (1.25 mg/mL) Cort + HF (2.5 mg/mL) Cort + HF (5 mg/mL)
Cort DA 10% 117.18 ± 14.18 67.40 ± 11.56## 98.01 ± 12.04 101.65 ± 24.17** 100.06 ± 24.60**
30% 157.50 ± 34.50 81.48 ± 49.68## 136.33 ± 42.53 127.50 ± 7.94** 136.12 ± 18.09**
50% 134.18 ± 39.12 87.23 ± 13.26## 103.78 ± 14.86 113.98 ± 25.40 117.15 ± 28.17
10% 0.88 ± 0.04 0.60 ± 0.03## 0.78 ± 0.21* 0.91 ± 0.03** 0.91 ± 0.08**
NE 30% 1.48 ± 0.07 1.18 ± 0.16# 1.54 ± 0.10* 1.58 ± 0.35* 1.68 ± 0.06**
50% 1.34 ± 0.17 0.83 ± 0.20## 1.42 ± 0.26** 1.42 ± 0.27** 1.49 ± 0.17**
10% 15.53 ± 6.20 7.88 ± 4.26## 11.89 ± 3.10 12.88 ± 2.65 13.76 ± 2.45
treated ACh 30% 20.60 ± 0.70 13.57 ± 3.05## 19.23 ± 1.85* 20.02 ± 5.05* 20.42 ± 5.25*
cells GABA 50% 20.88 ± 4.56 8.35 ± 2.41## 18.46 ± 0.67** 19.38 ± 2.97** 21.07 ± 3.39**
10% 97.59 ± 56.99 39.52 ± 14.56## 41.62 ± 16.01 57.18 ± 13.74 58.78 ± 12.29
30% 153.03 ± 20.91 102.35 ± 12.87## 120.32 ± 15.55 125.12 ± 37.04 123.93 ± 33.42
5-HT 50% 114.70 ± 38.33 55.43 ± 19.63## 112.06 ± 16.21* 113.40 ± 40.61* 111.75 ± 4.24*
10% 159.67 ± 20.00 107.76 ± 7.93## 119.09 ± 14.71 129.33 ± 17.66 121.22 ± 38.25
30% 195.50 ± 47.78 111.15 ± 31.92## 170.26 ± 38.25 204.25 ± 32.39** 205.86 ± 48.56**
DA 50% 150.03 ± 8.61 93.04 ± 9.03## 138.74 ± 31.51* 139.38 ± 31.00* 152.20 ± 24.80**
10% 29.97 ± 1.06 11.54 ± 2.88## 19.68 ± 8.22 24.16 ± 9.74* 26.74 ± 5.63**
30% 49.40 ± 11.72 18.66 ± 9.04## 24.11 ± 13.55 28.6 ± 3.65 29.62 ± 7.75
NE 50% 50.90 ± 23.14 19.61 ± 8.07## 28.40 ± 9.75 29.95 ± 10.18 29.64 ± 7.41
10% 1.94 ± 0.32 1.53 ± 0.12# 2.00 ± 0.23 2.00 ± 0.22* 1.99 ± 0.37*
30% 2.24 ± 0.10 1.58 ± 0.03## 1.91 ± 0.22** 1.98 ± 0.19** 1.99 ± 0.23**
50% 1.96 ± 0.14 1.50 ± 0.14## 1.77 ± 0.19 1.88 ± 0.18* 1.83 ± 0.19*
Glu 10% 36.51 ± 1.49 25.97 ± 2.68## 27.23 ± 4.63 28.81 ± 6.76 30.95 ± 2.94
treated ACh 30% 47.60 ± 19.10 28.45 ± 1.47# 36.79 ± 5.23 42.43 ± 3.50* 43.65 ± 3.90*
cells 50% 70.42 ± 13.11 32.36 ± 3.43## 51.48 ± 3.93* 53.71 ± 12.87** 57.03 ± 18.05**
10% 133.73 ± 11.64 51.84 ± 6.36## 88.69 ± 12.20** 101.46 ± 19.89** 105.08 ± 16.04**
GABA 30% 163.25 ± 6.36 74.51 ± 27.86## 128.30 ± 44.41* 133.05 ± 20.81* 133.88 ± 28.40*
50% 198.50 ± 16.74 90.44 ± 25.83## 151.50 ± 18.64** 154.75 ± 17.21** 150.94 ± 31.12**
10% 224.49 ± 24.98 152.40 ± 18.27## 177.35 ± 22.54 175.73 ± 36.75 183.31 ± 28.40
5-HT 30% 211.75 ± 22.14 166.51 ± 24.52# 172.98 ± 36.20 205.05 ± 19.46* 207.58 ± 24.62*
50% 173.50 ± 15.63 107.54 ± 32.38## 152.60 ± 20.64** 156.50 ± 23.87** 154.02 ± 9.52**
##P < 0.01 as compared with control group; *P < 0.05 and **P < 0.01 as compared with the corticosterone/glutamate group
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including both phenolic acid derivatives and flavonoids, ra-
ther than non-phenolics, were likely the active constituents.
In addition, this study is the first to demonstrate that the
phenolic acid derivatives in daylily conferred similar
neuroprotection to the flavonoids and yet the former
modulated the neurotransmitter release distinct from
the latter constituents.
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